76 related articles for article (PubMed ID: 25399296)
1. Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma.
Liu H; Liu W; Zhu B; Xu Q; Ni X; Yu J
Mol Cell Biochem; 2015 Jan; 399(1-2):1-5. PubMed ID: 25399296
[TBL] [Abstract][Full Text] [Related]
2. Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade.
Cha N; Liu W; Yang N; Xie S; Gao Y; Chen X; Wang X; Ren J
Tumour Biol; 2014 Oct; 35(10):10319-24. PubMed ID: 25034524
[TBL] [Abstract][Full Text] [Related]
3. Oncogenicity of LHX2 in pancreatic ductal adenocarcinoma.
Zhou F; Gou S; Xiong J; Wu H; Wang C; Liu T
Mol Biol Rep; 2014 Dec; 41(12):8163-7. PubMed ID: 25324171
[TBL] [Abstract][Full Text] [Related]
4. SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.
Zhou D; Bai F; Zhang X; Hu M; Zhao G; Zhao Z; Liu R
Tumour Biol; 2014 Oct; 35(10):9935-40. PubMed ID: 25001176
[TBL] [Abstract][Full Text] [Related]
5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
6. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.
Qi L; Wang ZY; Shao XR; Li M; Chen SN; Liu XQ; Yan S; Zhang B; Zhang XD; Li X; Zhao W; Pan JA; Zhao B; Zhang XD
Oncogene; 2020 Sep; 39(37):5964-5978. PubMed ID: 32753650
[TBL] [Abstract][Full Text] [Related]
7. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase.
Berry WL; Kim TD; Janknecht R
Int J Oncol; 2014 Apr; 44(4):1341-8. PubMed ID: 24481461
[TBL] [Abstract][Full Text] [Related]
13. LMX1A inhibits metastasis of gastric cancer cells through negative regulation of β-catenin.
Feng L; Xie Y; Zhao Z; Lian W
Cell Biol Toxicol; 2016 Apr; 32(2):133-9. PubMed ID: 27061089
[TBL] [Abstract][Full Text] [Related]
14. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
16. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
[TBL] [Abstract][Full Text] [Related]
17. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
[TBL] [Abstract][Full Text] [Related]
18. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
19. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
[TBL] [Abstract][Full Text] [Related]
20. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
